Everest Management Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Everest Management Corp's LLY Position: Q1 2026 in Review
Everest Management Corp increased its Eli Lilly (LLY) stake by 59% in Q1 2026, buying an estimated $254K and bringing the position to 676 shares worth $622K. The position accounts for 0.32% of the portfolio, ranked #41.
Everest Management Corp first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Everest Management Corp held 676 shares of Eli Lilly worth $622K as of Q1 2026.
- Everest Management Corp bought 251 Eli Lilly shares in Q1 2026, an estimated $254K.
- Eli Lilly made up 0.32% of Everest Management Corp's portfolio in Q1 2026, its #41 holding.
- Everest Management Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Everest Management Corp's 13F filing for Q1 2026, filed 7 May 2026.